Page last updated: 2024-10-31
nafamostat and Gram-Negative Bacterial Infections
nafamostat has been researched along with Gram-Negative Bacterial Infections in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Gram-Negative Bacterial Infections: Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cheadle, WG | 1 |
Hanasawa, K | 1 |
Gallinaro, RN | 1 |
Nimmanwudipong, T | 1 |
Kodama, M | 1 |
Polk, HC | 1 |
Other Studies
1 other study available for nafamostat and Gram-Negative Bacterial Infections
Article | Year |
---|---|
Endotoxin filtration and immune stimulation improve survival from gram-negative sepsis.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antithrombins; Benzamidines; End | 1991 |